Compounds > bismuth
Page last updated: 2024-08-26

bismuth and Adenocarcinoma

bismuth has been researched along with Adenocarcinoma in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19904 (36.36)18.7374
1990's3 (27.27)18.2507
2000's1 (9.09)29.6817
2010's1 (9.09)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Hisatomi, H; Iuchi, K; Shirai, S; Tasaki, Y1
Graham, DY; Howden, CW1
Berbeco, R; Detappe, A; Kunjachan, S; Lux, F; Parnandi, N; Reznichenko, E; Thomas, E; Tibbitt, MW; Tillement, O; Zavidij, O1
Anderson, TL; Atcher, RW; Nayak, TK; Norenberg, JP; Prossnitz, ER; Stabin, MG1
Chee, YC1
Harper, PV; Hines, JJ; Reba, RC; Rotmensch, J; Schwartz, JL; Whitlock, JL1
Parsonnet, J1
Atcher, RW; Brechbiel, MW; Hines, JJ; Langmuir, VK1
Imura, N; Kawamura, E; Matsuzaki, N; Miura, N; Naganuma, A; Satoh, M1
Imura, N; Koyama, Y; Naganuma, A; Satoh, M1
Imura, N; Naganuma, A; Satoh, M1

Reviews

1 review(s) available for bismuth and Adenocarcinoma

ArticleYear
Helicobacter pylori.
    Infectious disease clinics of North America, 1998, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Anti-Bacterial Agents; Bismuth; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma; Peptic Ulcer; Stomach Neoplasms

1998

Other Studies

10 other study(ies) available for bismuth and Adenocarcinoma

ArticleYear
Upregulation of nuclear factor (erythroid-derived 2)-like 2 protein level in the human colorectal adenocarcinoma cell line DLD-1 by a heterocyclic organobismuth(III) compound: Effect of organobismuth(III) compound on NRF2 signaling.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 125

    Topics: Adenocarcinoma; Antineoplastic Agents; Bismuth; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Down-Regulation; Gene Knockdown Techniques; Heme Oxygenase-1; Humans; Kelch-Like ECH-Associated Protein 1; NF-E2-Related Factor 2; Organometallic Compounds; Oxidative Stress; Signal Transduction; Time Factors; Up-Regulation

2020
Recent Developments Pertaining to H. pylori Infection.
    The American journal of gastroenterology, 2021, 01-01, Volume: 116, Issue:1

    Topics: Adenocarcinoma; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Pyrroles; Rifabutin; Stomach Neoplasms; Sulfonamides; Tetracycline; Treatment Outcome

2021
Ultrasmall Silica-Based Bismuth Gadolinium Nanoparticles for Dual Magnetic Resonance-Computed Tomography Image Guided Radiation Therapy.
    Nano letters, 2017, 03-08, Volume: 17, Issue:3

    Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Bismuth; Contrast Media; Gadolinium; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Nanoparticles; Radiotherapy, Image-Guided; Silicon Dioxide; Theranostic Nanomedicine; Tomography, X-Ray Computed

2017
Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.
    Nuclear medicine and biology, 2007, Volume: 34, Issue:2

    Topics: Adenocarcinoma; Alpha Particles; Beta Particles; Bismuth; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Radiation; Drug Delivery Systems; Humans; Lutetium; Pancreatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Receptors, Somatostatin; Treatment Outcome

2007
An unusual radiographic presentation of colonic carcinoma after medication for peptic ulcer.
    Singapore medical journal, 1980, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Aged; Bismuth; Colonic Neoplasms; Female; Humans; Peptic Ulcer; Radiography

1980
In vitro and in vivo studies on the development of the alpha-emitting radionuclide bismuth 212 for intraperitoneal use against microscopic ovarian carcinoma.
    American journal of obstetrics and gynecology, 1997, Volume: 176, Issue:4

    Topics: Adenocarcinoma; Alpha Particles; Animals; Bismuth; Female; Humans; Ovarian Neoplasms; Rabbits; Radioisotopes; Survival Analysis; Tumor Cells, Cultured

1997
Iodine-125-NRLU-10 kinetic studies and bismuth-212-NRLU-10 toxicity in LS174T multicell spheroids.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1990, Volume: 31, Issue:9

    Topics: Adenocarcinoma; Antibodies, Monoclonal; Bismuth; Cell Line; Colonic Neoplasms; Humans; In Vitro Techniques; Iodine Radioisotopes; Radioisotopes; Tumor Cells, Cultured

1990
Prevention of adverse effects of gamma-ray irradiation after metallothionein induction by bismuth subnitrate in mice.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:12

    Topics: Adenocarcinoma; Animals; Bismuth; Bone Marrow; Colonic Neoplasms; Gamma Rays; Leukemia P388; Male; Metallothionein; Mice; Mice, Inbred Strains; Radiation Injuries, Experimental; Radiation, Ionizing

1989
Induction of renal metallothionein allows increasing dose of an extensively used antitumor drug, cis-diamminedichloroplatinum.
    Experientia. Supplementum, 1987, Volume: 52

    Topics: Adenocarcinoma; Animals; Bismuth; Cisplatin; Colonic Neoplasms; Kidney; Kidney Diseases; Metallothionein; Mice; Neoplasm Transplantation

1987
Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination.
    Cancer chemotherapy and pharmacology, 1988, Volume: 21, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Bismuth; Carcinoma, Ehrlich Tumor; Cisplatin; Colonic Neoplasms; Doxorubicin; Heart; Kidney; Male; Metallothionein; Mice; Mice, Inbred ICR

1988